Mechanical Unloading Promotes Myocardial Energy Recovery in Human Heart Failure
暂无分享,去创建一个
Stephen T. C. Wong | Leif E. Peterson | Christopher J. Lyon | W. Hsueh | M. Loebe | O. Ilkayeva | C. Newgard | H. Taegtmeyer | K. Youker | A. Gupte | R. Stevens | B. Wenner | D. Hamilton | Zheng Yin | J. Estep | G. Torre-Amione | A. Cordero-Reyes | A. Cordero‐Reyes
[1] S. Sihag,et al. PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. , 2009, Journal of molecular and cellular cardiology.
[2] Colin Simpson,et al. Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People , 2009, Circulation.
[3] Xianlin Han,et al. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. , 2008, American journal of physiology. Heart and circulatory physiology.
[4] Inger Ekman,et al. Population Impact of Heart Failure and the Most Common Forms of Cancer: A Study of 1 162 309 Hospital Cases in Sweden (1988 to 2004) , 2010, Circulation. Cardiovascular quality and outcomes.
[5] I. T. de Almeida,et al. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling. , 2010, Biochimica et biophysica acta.
[6] Stefan Neubauer,et al. The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.
[7] R. Naviaux,et al. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. , 2007, Cell metabolism.
[8] Yuan-Tsong Chen,et al. ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. , 2004, The Journal of clinical investigation.
[9] D. Glower,et al. Metabolomic Profiling Reveals Distinct Patterns of Myocardial Substrate Use in Humans With Coronary Artery Disease or Left Ventricular Dysfunction During Surgical Ischemia/Reperfusion , 2009, Circulation.
[10] Pim van der Harst,et al. Telomere biology in healthy aging and disease , 2009, Pflügers Archiv - European Journal of Physiology.
[11] P. D. del Nido,et al. Impaired Mitochondrial Biogenesis Precedes Heart Failure in Right Ventricular Hypertrophy in Congenital Heart Disease , 2011, Circulation. Heart failure.
[12] P. Buttrick,et al. Reverse Remodeling With Left Ventricular Assist Devices: A Review of Clinical, Cellular, and Molecular Effects , 2011, Circulation. Heart failure.
[13] Olga Ilkayeva,et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.
[14] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.
[15] Céline Guilbeau-Frugier,et al. p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. , 2013, Antioxidants & redox signaling.
[16] L. Chin,et al. Telomere dysfunction induces metabolic and mitochondrial compromise , 2011, Nature.
[17] H. Taegtmeyer,et al. Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate. , 1991, The Journal of clinical investigation.
[18] Svati H Shah,et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.
[19] J. McMurray,et al. Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.
[20] N. Samani,et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study , 2007, The Lancet.
[21] H. McDaniel,et al. Glutamic dehydrogenase from rat heart mitochondria. II. Kinetic characteristics. , 1984, Journal of molecular and cellular cardiology.
[22] N. de Jonge,et al. Proteomic profiling of the human failing heart after left ventricular assist device support. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[23] I. Komuro,et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload , 2007, Nature.
[24] Elizabeth Murphy,et al. The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. , 2007, Cell metabolism.
[25] David Millington,et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance , 2004, Nature Medicine.
[26] Claire Redin,et al. A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans , 2012, Science.
[27] I. Komuro,et al. Ca2+/Calmodulin-Dependent Kinase II&dgr; Causes Heart Failure by Accumulation of p53 in Dilated Cardiomyopathy , 2010, Circulation.
[28] N. Silverman,et al. Abnormal mitochondrial respiration in failed human myocardium. , 2000, Journal of molecular and cellular cardiology.
[29] Rick B. Vega,et al. Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart. , 2013, Biochimica et biophysica acta.
[30] D. Kelly,et al. The PGC-1 cascade as a therapeutic target for heart failure. , 2011, Journal of molecular and cellular cardiology.
[31] Torsten Doenst,et al. PGC-1&bgr; Deficiency Accelerates the Transition to Heart Failure in Pressure Overload Hypertrophy , 2011, Circulation research.
[32] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Jensen,et al. Compensatory responses to pyruvate carboxylase suppression in islet beta-cells. Preservation of glucose-stimulated insulin secretion. , 2006, The Journal of biological chemistry.
[34] G. Couper,et al. Defective DNA Replication Impairs Mitochondrial Biogenesis In Human Failing Hearts , 2010, Circulation research.
[35] H. Taegtmeyer,et al. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. , 1991, The American journal of physiology.
[36] H. McDaniel,et al. Conditions for glutamate dehydrogenase activity in heart mitochondria. , 1993, Biochemical medicine and metabolic biology.
[37] O. Frazier,et al. Metabolic Gene Expression in Fetal and Failing Human Heart , 2001, Circulation.
[38] Leif E. Peterson,et al. Differential Roles of Cardiomyocyte and Macrophage Peroxisome Proliferator–Activated Receptor γ in Cardiac Fibrosis , 2008, Diabetes.
[39] S. Nagueh,et al. Imaging for Ventricular Function and Myocardial Recovery on Nonpulsatile Ventricular Assist Devices , 2012, Circulation.
[40] H A Krebs,et al. Utilization of energy-providing substrates in the isolated working rat heart. , 1980, The Biochemical journal.
[41] Dean Y. Li,et al. Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action , 2011, Current opinion in cardiology.
[42] O. Frazier,et al. Downregulation of Metabolic Gene Expression in Failing Human Heart before and after Mechanical Unloading , 2002, Cardiology.
[43] Magdi H. Yacoub,et al. Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy: A Prospective Study , 2011, Circulation.
[44] M. Blasco,et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation , 2003, The EMBO journal.
[45] J. Cleveland,et al. Incomplete Recovery of Myocyte Contractile Function Despite Improvement of Myocardial Architecture With Left Ventricular Assist Device Support , 2011, Circulation. Heart failure.
[46] Ò. Miró,et al. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. , 2000, Cardiovascular research.
[47] A. Garnier,et al. Control by Circulating Factors of Mitochondrial Function and Transcription Cascade in Heart Failure: A Role for Endothelin-1 and Angiotensin II , 2009, Circulation. Heart failure.
[48] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .